alpha-lapachone has been researched along with atovaquone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calil, FA; Castilho, MS; Chiappetta, ERC; David, JS; Emery, FS; Fumagalli, F; Leite, FHA; Mello, RB; Nonato, MC | 1 |
| Beteck, RM; Legoabe, LJ; Patel, OPS | 1 |
1 review(s) available for alpha-lapachone and atovaquone
| Article | Year |
|---|---|
Antimalarial application of quinones: A recent update.
Topics: Antimalarials; Dose-Response Relationship, Drug; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinones; Structure-Activity Relationship | 2021 |
1 other study(ies) available for alpha-lapachone and atovaquone
| Article | Year |
|---|---|
Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
Topics: Animals; Anthelmintics; Dihydroorotate Dehydrogenase; Drug Design; Humans; Ligands; Oxidoreductases Acting on CH-CH Group Donors; Quinones; Schistosoma mansoni; Schistosomiasis mansoni; Structure-Activity Relationship | 2019 |